Keyword
in
Collection
Date
to
Download Folder

0 items

Houston Voice, No. 1003, January 14, 2000
File 004
Citation
MLA
APA
Chicago/Turabian
Houston Voice, No. 1003, January 14, 2000 - File 004. 2000-01-14. University of Houston Libraries. University of Houston Digital Library. Web. December 15, 2017. http://digital.lib.uh.edu/collection/montrose/item/7109/show/7079.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

(2000-01-14). Houston Voice, No. 1003, January 14, 2000 - File 004. Montrose Voice. University of Houston Libraries. Retrieved from http://digital.lib.uh.edu/collection/montrose/item/7109/show/7079

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

Houston Voice, No. 1003, January 14, 2000 - File 004, 2000-01-14, Montrose Voice, University of Houston Libraries, accessed December 15, 2017, http://digital.lib.uh.edu/collection/montrose/item/7109/show/7079.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

URL
Embed Image
Compound Item Description
Title Houston Voice, No. 1003, January 14, 2000
Contributor
  • Hennie, Matthew A.
Publisher Window Media
Date January 14, 2000
Language English
Subject
  • LGBTQ community
  • LGBTQ people
  • Gay liberation movement
Place
  • Houston, Texas
Genre
  • newspapers
Type
  • Text
Identifier OCLC: 31485329
Rights In Copyright: This item is protected by copyright. Copyright to this resource is held by the creator or current rights holder, and the resource is provided here for educational purposes. It may not be reproduced or distributed in any format without permission of the copyright owner. Users assume full responsibility for any infringement of copyright or related rights.
Note This item was digitized from materials loaned by the Gulf Coast Archive and Museum (GCAM).
Item Description
Title File 004
Transcript HOUSTON VOICE • JANUARY 14, 2000 w& J+vm/UiZ+tAC&KJ /At<4l HIVVKULu^L-Y ^1 someOnt just did! Ill ^P VP VP SUSTIVA" is the first HIV druS approved to be taken once-a-day as part of your combination therapy. Just take three 200 mg capsules together once daily, with or without food; high fat meals should be avoided. Your doctor may suggest taking SUSTIVA at bedtime to reduce any side effects you may experience. SUSTIVA, an NNRTI*, must be used in combination with other HIV drugs. SUSTIVA is tough on HIV. It reduces the amount of virus in your blood and increases the number of CD4 cells. SUSTIVA can even be used in young children, 3 years of age or older This is based on results from controlled clinical tnals at 24 weeks. Presently, there are no results from controlled clinical trials showing the long-term effects of SUSTIVA. SUSTIVA has manageable side effects. Most side effects are mild to moderate and can be managed. The most significant side effects associated with SUSTIVA therapy have been nervous system symptoms (dizziness, trouble sleeping, drowsiness, trouble concentrating and/or abnormal dreams) and rash. These usually subside within the first two to four weeks of treatment. In a small number of patients, rash may be serious. Taking SUSTIVA at bedtime may help make nervous system symptoms less noticeable. •NNRTI - non-nudeoside reverse transcriptase inhibitor For more information on SUSTIVA, call I-800-4PHARMA or visit our website at http://www.sustjva.com For more Information on the updated DHHS Guidelines, i PDF file of the guidelines is available at http://www.hiv; Now listed among preferred anti-HIV drugs in government guidelines.1 Once Daily SUSTIVA efavirenz Pregnancy should be avoided in women receiving SUSTIVA because birth defects have been seen in primates dosed with SUSTIVA. Barrier contraception should always be used in combination with other methods of contraception. Talk to your doctor when you start taking SUSTIVA. SUSTIVA may change the effect of other medicines (including ones for HIV). Always tell your doctor if you are taking, starting or changing any prescription or non-prescnption medicine when taking SUSTIVA.Your doctor may change your medicines or change their dose. You should discuss your prior medical conditions (such as mental illness, substance abuse, hepatitis, etc.) with your doctor before taking SUSTIVA. We know that coping with HIV is difficult enough. Your treatment doesn't have to be. Ask your doctor about SUSTIVA. For more important information see the next page for Patient Information about SUSTIVA. FOR HIV Finally, a once daily medication to treat HIV. SUSTIVA. Ifs about time. www.sustiva.com l-&JKWnesfwtrWlJseofArrt<rWrW^ Department of Health and Human Services (DHHS). December 199ft SUSTTVA™ and the Sunburst Logo are trademarks of DuFtont Pharmaceuticals Company. Copyright © 1999 DuFbnt Pharmaceuticals Company. •tfiTnnlT^ DuPont Pharmaceuticals
File Name uhlib_31485329_n1003_003.jpg